ATP2C1

Calcium-transporting ATPase type 2C member 1 · P98194 · ATP2C1 on Sugi Atlas →

0 patent compounds predicted against ATP2C1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to ATP2C1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Pharmacogenomic Evaluation of Antihypertensive Responses PHASE4COMPLETED
PHOspholamban RElated CArdiomyopathy STudy - Intervention PHASE3COMPLETED
Pilot Study, Comparative, Single-center, Randomized, Crossover, Double-blind, Against Placebo, Testing the Effectiveness of Triheptanoin Oil in Alternating Hemiplegia of Childhood PHASE2COMPLETED
Prevention of Post-Cardiac Surgery Acute Kidney Injury by Proton Pump Inhibitor PHASE2COMPLETED
Prevention of Vitamin D Deficiency Following Pediatric CHD Surgery: a Phase II Dose Evaluation Randomized Controlled Trial Comparing Usual Care With a High Dose Pre-operative Supplementation Regimen Based on the Institute of Medicine Daily Upper Tolerable Intake Level PHASE2COMPLETED
Genetic Counseling and Lifestyle Change for Diabetes Prevention PHASE2UNKNOWN
Oxygen as an Acute Treatment in Alternating Hemiplegia of Childhood PHASE2COMPLETED
Post-Cardiac Surgery Acute Kidney Injury Prevention by Administration of Proton Pump Inhibitor (P2 Trial) PHASE2RECRUITING
Calcium Electroporation for Head and Neck Cancer PHASE1UNKNOWN
Natural History Study of ATP1A3-related Disease nanUNKNOWN
Genetic and Environmental Determinants of Hypertension nanCOMPLETED
Prevalence and Risk Factors of Nephrocalcinosis in Children at Sohag University Hospital nanUNKNOWN
The Energetic Origin of Neurodegeneration in MS nanCOMPLETED
Pharmacogenetics and Cardiovascular Events nanCOMPLETED
Piezo2-related Arthrogryposis & physiopathOLOgy 3 nanNOT_YET_RECRUITING
Coproporphyrine Isomers and Methotrexate Elimination nanCOMPLETED
Evaluation of A Clinical Diagnostic Test for CRDS nanRECRUITING
Ventricular Arrhythmias in Uremic Cardiomyopathy nanCOMPLETED
Exome Sequencing for Atypical Femoral Fractures nanCOMPLETED
Pediatric Cardiomyopathy Mutation Analysis nanRECRUITING
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia nanACTIVE_NOT_RECRUITING
Artificial Intelligence for the Prioritization of Genetic Background in Brugada Syndrome nanCOMPLETED
Evaluate the Effort Test as a Therapeutic Monitoring Tool in Acute Rhabdomyolyses nanCOMPLETED
Longitudinal Assessment of Atypical Tripeptidyl Peptidase 1 Enzyme Deficiency Patients nanACTIVE_NOT_RECRUITING
The Prevalence of RYR1-related Disease nanNOT_YET_RECRUITING
Registry of Unexplained Cardiac Arrest nanCOMPLETED
Genetic and Biohumoral Factors Involved in Menière's Disease and Their Correlation With Phenotypes nanRECRUITING
Establishment of Human Cellular Disease Models for Wilson Disease nanCOMPLETED
Rare Kidney Stone Consortium Biobank nanRECRUITING
Heart and Skeletal Muscle Problems in Neuroacanthocytosis nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a ATP2C1 binder may also engage these)

ProteinNameSimilarity
Q5R5K5 1.000 Q5R5K5 →
Q64566 1.000 Q64566 →
Q80XR2 1.000 Q80XR2 →
P57709 1.000 P57709 →
O59868 1.000 O59868 →
C1L360 0.997 C1L360 →
Q8R4C1 0.996 Q8R4C1 →
O43108 0.995 O43108 →
A7L9Z8 0.994 A7L9Z8 →
P13586 0.993 P13586 →
Q7XB51 0.992 Q7XB51 →
O75185 0.991 O75185 →
P22189 0.991 P22189 →
Q2RAS0 0.991 Q2RAS0 →
O22218 0.989 O22218 →
Q9SY55 0.988 Q9SY55 →
Q01896 0.988 Q01896 →
Q12691 0.988 Q12691 →
P13587 0.988 P13587 →
Q9M2L4 0.987 Q9M2L4 →
P23634 0.987 P23634 →
O34431 0.987 O34431 →
D3K0R6 0.987 D3K0R6 →
Q6Q477 0.987 Q6Q477 →
Q64542 0.987 Q64542 →
Q2QY12 0.987 Q2QY12 →
Q9XES1 0.986 Q9XES1 →
Q8Y8Q5 0.986 Q8Y8Q5 →
Q65X71 0.986 Q65X71 →
Q42556 0.986 Q42556 →